What Avenue Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 1 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 1 reported trade in the last 12 months is in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Coronado Biosciences Inc | 10% owner | Jan 02 | Grant / award · A | +111,209 | — | — | 439,733 |
| Coronado Biosciences Inc | 10% owner | Mar 31 | Grant / award · A | +33,724 | — | — | 328,524 |
| Herskowitz Neil | Director | Dec 02 | Open-market sale · S | −23 | $2.00 | −$46 | 97 |
| Kranzler Jay D | Director | Nov 05 | Open-market sale · S | −61 | $2.24 | −$137 | 559 |
| Kranzler Jay D | Director | Sep 30 | Open-market buy · P | +497 | $2.50 | +$1.24K | 620 |
| Kranzler Jay D | Director | Sep 27 | Open-market buy · P | +3 | $2.40 | +$7.2 | 123 |
| Jin David | Interim PFO and COO | Sep 23 | Grant / award · A | +65,000 | — | — | 65,000 |
| MacLean Alexandra | Chief Executive Officer | Sep 23 | Grant / award · A | +170,000 | — | — | 170,000 |
| Coronado Biosciences Inc | 10% owner | Apr 16 | Grant / award · A | +413,507 | — | — | 3,547,393 |
| Coronado Biosciences Inc | 10% owner | Jan 02 | Grant / award · A | +2,101,496 | — | — | 3,133,886 |
| Davidow Robert L | 10% owner | Dec 11 | Open-market sale · S | −20,000 | $0.14 | −$2.8K | 80,000 |
| Davidow Robert L | 10% owner | Dec 11 | Sale for tax withholding · S | −128,000 | $0.14 | −$17.9K | 147,000 |
| Davidow Robert L | 10% owner | Dec 11 | Sale for tax withholding · S | −126,000 | $0.14 | −$17.6K | 215,800 |
| Davidow Robert L | 10% owner | Dec 11 | Sale for tax withholding · S | −61,000 | $0.14 | −$8.54K | 74,000 |
| Davidow Robert L | 10% owner | Dec 11 | Open-market sale · S | −18,000 | $0.15 | −$2.7K | 22,000 |
| Davidow Robert L | 10% owner | Dec 11 | Sale for tax withholding · S | −264,000 | $0.14 | −$37K | 681,000 |
| Coronado Biosciences Inc | 10% owner | Sep 08 | Open-market buy · P | +418,410 | $0.72 | +$301K | 1,032,390 |
| Rosenwald Lindsay A Md | Director | Sep 08 | Open-market buy · P | +348,675 | $0.72 | +$251K | 354,318 |
| Coronado Biosciences Inc | 10% owner | Mar 31 | Grant / award · A | +52,419 | — | — | 613,980 |
| Coronado Biosciences Inc | 10% owner | Jan 03 | Grant / award · A | +231,316 | — | — | 561,561 |
Loading...
